News

Heart Disease in SLE Called 'Startlingly Worrying'


 

Antibodies against apolipoprotein A1 in HDL cholesterol also were elevated and were associated with the presence of tumor necrosis factor. Whether these anti-apo A1 antibodies play a pathogenic role—for example, by inhibiting the anti-inflammatory properties of HDL—is under investigation, Dr. Su said.

Homocysteine. Hyperhomocysteinemia in patients with lupus correlates with markers of inflammatory activity and is a risk factor for cardiovascular disease, said Elisabet Svenungsson, M.D. In fasting blood samples obtained from a cohort of 208 patients, homocysteine levels were associated with acute phase reactants including C-reactive protein, serum amyloid A protein, fibrinogen, and complement.

Hyperhomocysteinemia also correlated with the presence of arterial disease and nephritis. “It may cause endothelial activation and damage and thus adds to the inflammatory burden that we believe renders SLE patients highly susceptible to cardiovascular disease,” she said.

—Nancy Walsh

Pages

Recommended Reading

Transplants Prolong AL Amyloidosis Survival Rates
MDedge Rheumatology
Heart Benefits of Antimalarials in SLE Posited
MDedge Rheumatology
Biologic Doesn't Boost Remission Of Wegener's
MDedge Rheumatology
New Raynaud's: Nail Folds Predict Scleroderma
MDedge Rheumatology
A Rare Scleroderma Look-Alike: Nephrogenic Fibrosing Dermopathy
MDedge Rheumatology
B-Cell Depletion May Benefit Sjögren's Patients
MDedge Rheumatology
High-Dose IV Steroid Allows Prednisone Tapering in Giant Cell Arteritis
MDedge Rheumatology
Safety of HCQ in Pregnancy Backed By Small Studies
MDedge Rheumatology
First Inhaled Treatment Approved for PAH
MDedge Rheumatology
Fractures, Osteoporosis Common in SLE Patients
MDedge Rheumatology